A Novel Parallel Wire-based Antegrade Dissection Re-entry Technique for Failed Retrograde Attempt of Coronary Chronic

Yuanji Ma1,2,3, Hao Lu1,2,3, Yiqing Hu1,2,3

  • 1Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.

PubMed

Insights

A new hybrid technique, parallel wire-based antegrade dissection re-entry (PW-ADR), successfully treats complex coronary chronic total occlusions (CTO) when other methods fail. A risk score helps predict potential technical failures in these challenging CTO interventions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Coronary chronic total occlusion (CTO) interventions have advanced, improving success rates.
  • Antegrade dissection re-entry (ADR) is key for long CTOs but can fail, especially with poor collaterals.
  • The retrograde approach may also be unsuccessful in complex CTO cases.

Purpose of the Study:

  • To evaluate the efficacy of a novel hybrid algorithm, parallel wire-based ADR (PW-ADR), for CTO interventions.
  • To assess the success rate and safety of PW-ADR in patients with failed retrograde approaches.
  • To develop a risk nomogram for predicting technical failure in PW-ADR procedures.

Main Methods:

  • A retrospective analysis of 57 patients undergoing PW-ADR at a single center.
  • PW-ADR combines parallel wire technique (PWT) with device-based ADR for complex CTOs.
  • A risk nomogram was developed using predictor variables for technical failure.

Main Results:

  • PW-ADR achieved technical and procedural success in 80.7% of cases (46/57).
  • Low rates of in-hospital complications and 1-year major adverse cardiac events (MACE) were observed.
  • The risk nomogram, incorporating vessel tortuosity, J-CTO score, and antegrade coronary angiography (CAG) times, showed high accuracy (AUROC 0.947) in predicting technical failure.

Conclusions:

  • The hybrid PW-ADR technique offers a promising alternative for complex CTO interventions.
  • The developed risk nomogram can identify high-risk patients, potentially guiding treatment strategy adjustments.
  • PW-ADR demonstrates a favorable success rate and safety profile for challenging CTO lesions.
Abstract